Market Tracker

01/29 6:05pm ET

Nektar Therapeutics (NASDAQ:NKTR)

15.06
Data as of Jan 29
 +0.54 / +3.72%
Today’s Change
10.10
Today|||52-Week Range
17.53
-2.84%
Year-to-Date

Today’s Trading

Previous close14.52
Today’s open14.60
Day’s range14.27 - 15.08
Volume761,007
Average volume (3 months)1,057,385
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 01/29/2015

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+69.13%
Earnings growth (next 5 years)+53.58%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc-0.80-2.58%
ABCOAdvisory Board Co+1.06+2.29%
DYAXDyax Corp+0.61+4.02%
PRAHPRA Health Sciences ...+1.09+4.17%
Data as of 3:59pm ET, 01/29/2015

Financials

Next reporting dateFebruary 25, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts